Global Bovine Serum Albumin Market Size, Trends and Growth Opportunity, By Products (Human Serum Albumin, Bovine Albumin, and Recombinant Serum Albumin), By Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient, Others), By Region and Forecast Till 2027.
Blood plasma contains albumin, a globular protein that is water soluble. It is created in the liver and necessary for both blood volume management and the movement of molecules containing enzymes, hormones, and bile salts. It is typically offered in recombinant, bovine, and human versions. They are essential for preserving intravascular colloid osmotic pressure (COP) and stopping fluid leakage into the tissue.
Global Bovine Serum Albumin Market
The Global Bovine Serum Albumin Market was valued at US$5.56 billion in 2021 and it is expected to reach at US$16.42 billion in 2027 at a CAGR of 14.28% during forecast period 2022-2027.Blood plasma contains albumin, a globular protein that is water soluble. It is created in the liver and necessary for both blood volume management and the movement of molecules containing enzymes, hormones, and bile salts. It is typically offered in recombinant, bovine, and human versions. They are essential for preserving intravascular colloid osmotic pressure (COP) and stopping fluid leakage into the tissue.
Market Drivers
One of the key factors propelling market expansion is the rising incidence of chronic medical conditions worldwide. The treatment of hypoalbuminemia, nephrosis, renal dialysis, liver failure, hypovolemia, acute respiratory distress syndrome (ARDS), and hypovolemia with albumin is widespread. Growth in the market is also being driven by the ageing population, which is more susceptible to such disorders.Market Restraints
The development of the bovine serum albumin market may be hampered by adverse reactions and a rising trend toward serum-free solutions. The expansion of the albumin market may be constrained by the adoption of alternatives for albumin in replacement therapies and other applications.Covid-19 Impact on Bovine Serum Albumin Market
The manufacturing, supply, and research of reagents and consumables have all been adversely affected by the unexpected onset of COVID-19 cases. Additionally, the pandemic's unfavourable effects on the bovine serum albumin market in the previous year affected a number of other enterprises. The application of lockdown to preserve social distance as a result of the coronavirus has resulted in the closure of industrial operations. The pandemic disrupted other industrial operations in addition to basic supplies.Market Segmentation
The global bovine serum albumin market segmented into product and application. On the basis of product it segmented into human serum albumin, bovine albumin, and recombinant serum albumin. On the basis of application it segmented into therapeutic, drug delivery, culture media, vaccine ingredient, others.Regional Analysis
The global bovine serum albumin market segmented into five regions North America, Europe, Latin America, Asia Pacific, Middle East and Africa. Bovine serum albumin's global market is anticipated to be dominated by Asia-Pacific in terms of percentage share throughout the forecast period. The presence of a large patient pool, an increase in the usage of albumin for illness treatment, and an increased emphasis on improved diagnostics are the main factors propelling the growth of the albumin market in Asia-Pacific.Key Players
Various key players are listed in this report such as Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc (U.S.), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (U.S.), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (U.S.), Rocky mountain biologicals (U.S.), BelHealth investment partners, LLC (U.S.), Bio-Techne Corporation (U.S.).Market Taxonomy
By Products
- Human Serum Albumin
- Bovine Albumin
- Recombinant Serum Albumin
By Application
- Therapeutic
- Drug Delivery
- Culture Media
- Vaccine Ingredient
- Others
Key Question Addressed by the Report
- What are the Key Opportunities in Global Bovine Serum Albumin Market?
- What will be the growth rate from 2022 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the role of key players in the value chain?
- What is the competitive Landscape in the industry?
Table of Contents
1 Introduction
2 Research Methodology
4 Global Bovine Serum Albumin Market Outlook
5 Global Bovine Serum Albumin Market, By Product
6 Global Bovine Serum Albumin Market, By Application
7 Global Bovine Serum Albumin Market, By Region
8 North America Bovine Serum Albumin Analysis and Forecast (2022-2027)
9 Europe Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
10 Asia Pacific Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
11 Latin America Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
12 Middle East Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
13 Competitive Analysis
14 Company Profiles
Companies Mentioned
- Thermo Fisher Scientific (U.S.)
- Bio-Rad Laboratories Inc (U.S.)
- Merck KGAA (Germany)
- Itoham Yonekyu Holdings Inc (Japan)
- Proliant Biologicals (U.S.)
- Kraeber & Co Gmbh (Germany)
- Rockland Immunochemicals Inc (U.S.)
- Rocky mountain biologicals (U.S.)
- BelHealth investment partners LLC (U.S.)
- Bio-Techne Corporation (U.S.).
